Research Mission

Mental disorders are a leading cause of disability worldwide, yet many current treatments lack precision. NEMO (Neuromodulation of Emotion) is an interdisciplinary team of clinician-scientists committed to advancing patient-centered precision psychiatry. By combining neuroscience, psychology, and data science, we translate fundamental discoveries into highly personalized interventions. Our research spans four core areas:

Prevention: We study how social factors (like loneliness) and environmental challenges (like climate change) impact emotional resilience to develop early-intervention strategies.

Personalized Intervention: We advance targeted treatments for severe psychiatric disorders, specializing in biomarker-informed neuromodulation, such as fMRI-guided theta burst stimulation (TBS).

AI-Supported Digital Aftercare: We create intelligent digital companions that provide continuous monitoring and adaptive support for patients in their everyday lives.

Patient-Centered Outcomes: We measure treatment success through the patient’s eyes, integrating real-world experiences to ensure value-based precision psychiatry.

Explore examples of our current research below.